ArticleJournal of experimental & clinical cancer research : CR2024

A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice.

Maria Laura De Angelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.